You are here

Erythropoiesis-Stimulating Agents in the Treatment of Anaemia in Cancer Patients: ESMO Clinical Practice Guidelines

D. Schrijvers, H. De Samblanx, F. Roila

Annals of Oncology 2010; 21(Supplement 5): v244–v247


Anaemia is defined as a reduction of the haemoglobin (Hb) concentration, red-cell count or packed cell volume below normal levels. Mild anaemia is defined as an Hb of ≤11.9 g/dl and ≥10 g/dl, moderate anaemia as an Hb of ≤9.9 and ≥8.0 g/dl and severe anaemia as an Hb of <8.0 g/dl.

Search this site

Stay up-to-date with our monthly e-alert

If you want to regularly receive information on what is happening in Quality of Life in Oncology research sign up to our e-alert.

Subscribe »

QOL (Quality of Life) newsletter e-alert

NEW! Free access to the digital version of a new publication in Cancer Supportive Care

Cancer cachexia: mechanisms and progress in treatment

Authors: Egidio Del Fabbro, Kenneth Fearon, Florian Strasser

This book was supported by an educational grant from Helsinn Healthcare SA.

Featured videos

Quality of Life promotional video

Made possible by an educational grant from Helsinn

Helsinn does not have any influence on the content and all items are subject to independent peer and editorial review

Society Partners

European Cancer Organisation Logo